Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer

被引：0

作者：

Ardavanis, A

Scorilas, A

Amanatidou, A

Gerakini, F

Missitzis, I

Garoufali, A

Pissakas, G

Pateras, C

Apostolikas, N

Rigatos, G

Yiotis, I

机构：

[1] ST SAVVAS CANC HOSP,HORMONAL RECEPTORS LAB,ATHENS 11522,GREECE

[2] ST SAVVAS CANC HOSP,BREAST CLIN,ATHENS 11522,GREECE

[3] ST SAVVAS CANC HOSP,RADIOTHERAPY DEPT 2,ATHENS 11522,GREECE

[4] ST SAVVAS CANC HOSP,PATHOL LAB,ATHENS 11522,GREECE

来源：

ANTICANCER RESEARCH | 1997年 / 17卷 / 2B期

关键词：

breast cancer; prognostic factors; cathepsin D;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

One hundred and seventy three women were followed-up for a median of 62 months after surgery for Stage I-III breast cancer: The concentration of cathepsin D (CD) in tumor cytosols was compared to the standard prognostic factors for the disease and related to relapse free and overall survival and type of relapse. Three groups were identified with different prognostic profile. High CD levels significantly shorten DFS ill both node-negative and node-positive patients; a correlation between high cathepsin D levels and locoregional relapse should also be noted. This marker should be included in the initial evaluation of breast cancer as an indicator of invasiveness.

引用

页码：1405 / 1409

页数：5

共 50 条

[31] Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients
Korkolis, DP
Tsoli, E
Fouskakis, D
Yiotis, J
Koullias, GJ
Giannopoulos, D
Papalambros, E
Nikiteas, NI
Spiliopoulou, CA
Patsouris, E
Asimacopoulos, P
Gorgoulis, VG
ANTICANCER RESEARCH, 2004, 24 (3B) : 2061 - 2068
[32] Biological and clinical significance of cathepsin D in breast cancer metastasis
Garcia, M
Platet, N
Liaudet, E
Laurent, V
Derocq, D
Brouillet, JP
Rochefort, H
STEM CELLS, 1996, 14 (06) : 642 - 650
[33] Immunohistochemical visualisation of cathepsin-D expression in breast cancer
Barthell, Elisabeth
Mylonas, Ioannis
Shabani, Naim
Kunze, Susanne
Kuhn, Christina
Jeschke, Udo
Friese, Klaus
ANTICANCER RESEARCH, 2007, 27 (4A) : 2035 - 2039
[34] Prognostic value of circulating tumor cells in primary and metastatic breast cancer
Aurilio, Gaetano
Sciandivasci, Angela
Munzone, Elisabetta
Sandri, Maria Teresa
Zorzino, Laura
Cassatella, Maria Cristina
Verri, Elena
Rocca, Maria Cossu
Nole, Franco
EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (02) : 203 - 214
[35] P53 ASSOCIATED WITH CATHEPSIN-D IN PRIMARY BREAST-CANCER
MARSIGLIANTE, S
LEO, G
MOTTAGHI, A
BISCOZZO, L
GRECO, S
STORELLI, C
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1993, 23 (02) : 102 - 108
[36] p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
Guerra, Emanuela
Cimadamore, Alessia
Simeone, Pasquale
Vacca, Giovanna
Lattanzio, Rossano
Botti, Gerardo
Gatta, Valentina
D'Aurora, Marco
Simionati, Barbara
Piantelli, Mauro
Alberti, Saverio
BMC CANCER, 2016, 16
[37] p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
Emanuela Guerra
Alessia Cimadamore
Pasquale Simeone
Giovanna Vacca
Rossano Lattanzio
Gerardo Botti
Valentina Gatta
Marco D’Aurora
Barbara Simionati
Mauro Piantelli
Saverio Alberti
BMC Cancer, 16
[38] pS2 protein, EGFR and cathepsin D in association with established prognostic factors in early recurrence of breast cancer
Schmidt, R
Sorger, D
Walter, F
Schonfelder, M
Preiss, R
ONKOLOGIE, 1996, 19 (02): : 176 - 180
[39] Immunohistochemical detection of cathepsin D in low grade breast invasive cancer
Lazaris, AC
Theodoropoulos, GE
Diamantopoulos, AK
Anastassopoulos, PD
Davaris, PS
ANTICANCER RESEARCH, 1997, 17 (4A) : 2651 - 2655
[40] Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview
Rochefort, H
Garcia, M
Glondu, M
Laurent, V
Liaudet, E
Rey, JM
Roger, P
CLINICA CHIMICA ACTA, 2000, 291 (02) : 157 - 170

← 1 2 3 4 5 →